Show simple item record

dc.contributor.authorPillay, Prinitha*
dc.contributor.authorFord, Nathan*
dc.contributor.authorShubber, Zara*
dc.contributor.authorFerrand, Rashida A*
dc.date.accessioned2013-10-16T22:38:30Z
dc.date.available2013-10-16T22:38:30Z
dc.date.issued2013-07
dc.identifier.citationOutcomes for Efavirenz versus Nevirapine-Containing Regimens for Treatment of HIV-1 Infection: A Systematic Review and Meta-Analysis. 2013, 8 (7):e68995 PLoS ONEen_GB
dc.identifier.issn1932-6203
dc.identifier.pmid23894391
dc.identifier.doi10.1371/journal.pone.0068995
dc.identifier.urihttp://hdl.handle.net/10144/303533
dc.description.abstractThere is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first-line antiretroviral therapy (ART).
dc.language.isoenen
dc.publisherPLoSen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectHIV/AIDSen_GB
dc.titleOutcomes for Efavirenz versus Nevirapine-Containing Regimens for Treatment of HIV-1 Infection: A Systematic Review and Meta-Analysisen
dc.contributor.departmentWits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. prinithapillay@yahoo.co.uken_GB
dc.identifier.journalPloS ONEen_GB
refterms.dateFOA2019-03-04T10:49:46Z
html.description.abstractThere is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first-line antiretroviral therapy (ART).


Files in this item

Thumbnail
Name:
Pillay et al. - 2013 - Outcomes ...
Size:
1.538Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record